OpenAlex
PricingAboutJobs
Log inGet started
Work

Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study

HTML

Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Diabetes & Endocrinology
DOI: 10.1016/s2213-8587(15)00417-9
Authors: Michael A Weber, Traci A Mansfield, Valerie A Cain, Nayyar Iqbal, Shamik Parikh, Agata Ptaszynska
Institutions: State University of New York, SUNY Downstate Health Sciences University, AstraZeneca (United States), Bristol-Myers Squibb (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: dapagliflozin, SGLT2 inhibitors, type 2 diabetes, hypertension, blood pressure reduction, glycemic control, HbA1c, combination antihypertensive therapy, renin-angiotensin system inhibitors, insulin, adverse events, drug safety, ambulatory blood pressure monitoring, cardiovascular risk reduction, renal protection, diabetic nephropathy, diabetic retinopathy, diabetic maculopathy, diabetic neuropathy, diabetic cardiomyopathy, diabetic osteoporosis
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2187514862
FWCI: 17.38
Cites: 24
Cited by: 273
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms